Literature DB >> 22477260

The NPY system and its neural and neuroendocrine regulation of bone.

Ee Cheng Khor1, Paul Baldock.   

Abstract

The past decade has seen a significant expansion of our understanding of the interaction between the neural system and bone. While innervation of bone was long appreciated, the discovery of central relays from the hypothalamus to the cells of bone has seen the identification of a number of efferent neural pathways to bone. The neuropeptide Y (NPY) system has proven to represent a major central pathway, regulating the activity of osteoblasts and osteoclasts, through signaling of central and peripheral ligands, through specific receptors within the hypothalamus and the osteoblast. Moreover, this pathway is now recognized as acting to coordinate both skeletal and energy homeostasis. This review examines the mechanism and actions of the NPY pathway to regulate bone mass and bone cell activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22477260     DOI: 10.1007/s11914-012-0102-7

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  84 in total

1.  Regional distribution of Y-receptor subtype mRNAs in rat brain.

Authors:  R M Parker; H Herzog
Journal:  Eur J Neurosci       Date:  1999-04       Impact factor: 3.386

2.  ATP-Dependent inhibition of Ca2+-activated K+ channels in vascular smooth muscle cells by neuropeptide Y.

Authors:  Z Xiong; D W Cheung
Journal:  Pflugers Arch       Date:  1995-11       Impact factor: 3.657

3.  Identification of two isoforms of mouse neuropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomic structure, and functional expression of the receptors.

Authors:  M Nakamura; C Sakanaka; Y Aoki; H Ogasawara; T Tsuji; H Kodama; T Matsumoto; T Shimizu; M Noma
Journal:  J Biol Chem       Date:  1995-12-15       Impact factor: 5.157

4.  Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.

Authors:  K Tatemoto; M Carlquist; V Mutt
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

5.  Distribution of CGRP-, VIP-, D beta H-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat.

Authors:  E L Hill; R Elde
Journal:  Cell Tissue Res       Date:  1991-06       Impact factor: 5.249

6.  Inhibitory effect of NPY on isoprenaline-induced osteoclastogenesis in mouse bone marrow cells.

Authors:  Shinobu Amano; Michitsugu Arai; Shigemi Goto; Akifumi Togari
Journal:  Biochim Biophys Acta       Date:  2007-03-01

7.  Neuropeptide y and neuropeptide y y5 receptor interaction restores impaired growth potential of aging bone marrow stromal cells.

Authors:  Koichi Igura; Husnain Kh Haider; Rafeeq P H Ahmed; Sulaiman Sheriff; Muhammad Ashraf
Journal:  Rejuvenation Res       Date:  2011-05-19       Impact factor: 4.663

8.  Identification of high-risk individuals for hip fracture: a 14-year prospective study.

Authors:  Nguyen D Nguyen; Chatlert Pongchaiyakul; Jacqueline R Center; John A Eisman; Tuan V Nguyen
Journal:  J Bone Miner Res       Date:  2005-05-31       Impact factor: 6.741

9.  Fat mass is an important determinant of whole body bone density in premenopausal women but not in men.

Authors:  I R Reid; L D Plank; M C Evans
Journal:  J Clin Endocrinol Metab       Date:  1992-09       Impact factor: 5.958

10.  Expression of the human neuropeptide tyrosine Y1 receptor.

Authors:  J Wharton; L Gordon; J Byrne; H Herzog; L A Selbie; K Moore; M H Sullivan; M G Elder; G Moscoso; K M Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

View more
  8 in total

Review 1.  Brain to bone: What is the contribution of the brain to skeletal homeostasis?

Authors:  Anna Idelevich; Roland Baron
Journal:  Bone       Date:  2018-05-16       Impact factor: 4.398

Review 2.  Endocrine regulation of bone and energy metabolism in hibernating mammals.

Authors:  Alison H Doherty; Gregory L Florant; Seth W Donahue
Journal:  Integr Comp Biol       Date:  2014-02-19       Impact factor: 3.326

Review 3.  Osteoporosis and multiple sclerosis: risk factors, pathophysiology, and therapeutic interventions.

Authors:  Sahil Gupta; Irfan Ahsan; Naeem Mahfooz; Noureldin Abdelhamid; Murali Ramanathan; Bianca Weinstock-Guttman
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

4.  [Neuropeptide Y Y1 receptor antagonist PD160170 promotes osteogenic differentiation of rat bone marrow mesenchymal stem cells in vitro and femoral defect repair in rats].

Authors:  Song Liu; Jian-Qun Wu; Ji-Jie Hu; Le Wang; Zhao Wang; Huan Meng; Ling-Jian Zhuo; Jian-Xiong Zheng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-06-20

Review 5.  Crosstalk between Bone and Nerves within Bone.

Authors:  Qian-Qian Wan; Wen-Pin Qin; Yu-Xuan Ma; Min-Juan Shen; Jing Li; Zi-Bin Zhang; Ji-Hua Chen; Franklin R Tay; Li-Na Niu; Kai Jiao
Journal:  Adv Sci (Weinh)       Date:  2021-02-10       Impact factor: 16.806

Review 6.  Exploring the effect of the "quaternary regulation" theory of "peripheral nerve-angiogenesis-osteoclast-osteogenesis" on osteoporosis based on neuropeptides.

Authors:  Shuhua Liu; Tongying Chen; Ruolin Wang; Hongxing Huang; Sai Fu; Yu Zhao; Shihao Wang; Lei Wan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-02       Impact factor: 6.055

7.  Beyond glycemic control in diabetes mellitus: effects of incretin-based therapies on bone metabolism.

Authors:  Elena Ceccarelli; Elisa G Guarino; Daniela Merlotti; Aurora Patti; Luigi Gennari; Ranuccio Nuti; Francesco Dotta
Journal:  Front Endocrinol (Lausanne)       Date:  2013-06-18       Impact factor: 5.555

8.  Neuropeptide Y upregulates Runx2 and osterix and enhances osteogenesis in mouse MC3T3‑E1 cells via an autocrine mechanism.

Authors:  Bo Zhang; Xiaolei Zhang; Juan Xiao; Xuguang Zhou; Yuan Chen; Chunzheng Gao
Journal:  Mol Med Rep       Date:  2020-09-14       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.